Internal Server Error

23andMe - About the company

23andMe is an acquired company based in Sunnyvale (United States), founded in 2006 by Anne Wojcicki, Linda Avey and Paul Cusenza. It operates as a Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. 23andMe has raised $944M in funding from investors like Fidelity Investments, Sequoia Capital and Google Ventures, with last known valuation of $305M. The company has 79 active competitors, including 12 funded and 11 that have exited. Its top competitors include companies like Ancestry, Helix and Color.

Sectors and market segments that 23andMe operate in

23andMe serves in the HealthTech, Life Sciences market segments.The primary business model of 23andMe are:

Company Details

Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. The platform provides a study regarding an individual's ancestry, genealogy, and inherited traits. The company also markets its data is categorized and searchable form to researchers and scientists.
Social
XFacebook
Email ID
*****@23andme.com
Phone Number
+1 **********
Registered Address
Sunnyvale, California
Key Metrics
Founded Year
2006
Location
Sunnyvale, United States
Stage
Acquired
Total Funding
$944M in 21 rounds
Latest Funding Round
Last Known Valuation
$305M as on Jun 13, 2025
Ranked
Annual Revenue
$100M - $500M as on Mar 31, 2025
Employee Count
555 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by TTAM Research Institute (Jun 13, 2025)

23andMe's acquisition details

23andMe got acquired by TTAM Research Institute on Jun 13, 2025 at an acquisition amount of $*****.
Click here to take a look at 23andMe's acquisition in detail
Sign up to download 23andMe's company profile

23andMe's funding and investors

23andMe has raised a total funding of $944M over 21 rounds. Its first funding round was on May 22, 2007. Its latest funding round was a Post IPO round on Nov 03, 2023 for $20M. 1 investor participated in its latest round. 23andMe has 33 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of 23andMe:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Nov 03, 2023
$20M
Post IPO
-
-
-
Dec 09, 2020
$82.5M
Series F
-
-
-
Jul 24, 2018
$300M
Series F
$1.75B
-
-
lockAccess funding benchmarks and valuations. Sign up today!

23andMe's founders and board of directors

Founder? Claim Profile
The founders of 23andMe are Anne Wojcicki, Linda Avey and Paul Cusenza. Anne Wojcicki is the CEO of 23andMe.
Here are the details of 23andMe's key team members:

23andMe's employee count trend

23andMe has 555 employees as of May 26. Here is 23andMe's employee count trend over the years:
Employee count trend for 23andMe
lockUncover 23andMe's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

23andMe's Competitors and alternates

Top competitors of 23andMe include Ancestry, Helix and Color. Here is the list of Top 10 competitors of 23andMe, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Ancestry
Ancestry
1996, Lehi (United States), Acquired
Provider of an online genealogy platform offering a host of services
$446M
80/100
2nd
Logo for 23andMe
23andMe
2006, Sunnyvale (United States), Acquired
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
$944M
77/100
3rd
Logo for Helix
Helix
2015, San Francisco (United States), Series E
Provider of a genomic database for clinical research
$435M
71/100
4th
Logo for Color
Color
2013, Burlingame (United States), Series E
Provider of end-to-end Virtual clinic offering cancer-based solutions
$491M
66/100
5th
Logo for Nucleus Genomics
Nucleus Genomics
2021, Manhattan (United States), Series A
Provider of genetic testing kits for rare variant analysis
$32M
62/100
6th
Logo for Genomind
Genomind
2009, King Of Prussia (United States), Series C
Developer of genetic tests for personalised medicines to enhance mental health treatment
$64.4M
56/100
7th
Logo for Veritas Genetics
Veritas Genetics
2014, Danvers (United States), Acquired
Provider of genetic testing products
$53.4M
55/100
8th
Logo for Counsyl
Counsyl
2007, San Francisco (United States), Acquired
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
$113M
54/100
9th
Logo for Digbi Health
Digbi Health
2018, Mountain View (United States), Series A
Provider of personalized healthcare on basis of DNA testing
$8.5M
49/100
10th
Logo for Recombine
Recombine
2011, New York City (United States), Acquired
Genetic testing services
$12.1M
48/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on 23andMe's competitors? Click here to see the top ones

23andMe's Investments and acquisitions

23andMe has made 2 investments in companies including Halo and Orchid. 23andMe has also acquired 2 companies including Icebreaker Health and CureTogether.
Here is the list of investments & acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Sep 21, 2022
Investments
2016
Chicago (United States)
Oct 22, 2021
Acquisition
2014
San Francisco (United States)
Apr 07, 2021
Investments
2019
Armadale (Australia)
lockWant to know more about where corporates are investing? Sign up today!

Reports related to 23andMe

Here is the latest report on 23andMe's sector:

News related to 23andMe

lockFilter this list
Media has covered 23andMe for a total of 16 events in the last 1 year, 5 of them have been about company updates and 2 about people movement.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about 23andMe

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford